Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Viatris Inc
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
18.0%
-5.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Pfizer
Competitor Displacement Rate
20.0%
Competitors are displacing Viatris Inc in 20.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Viatris faces strong competition in the generic and biosimilar market from established players with larger distribution networks. Their portfolio may not capture emerging therapeutic areas effectively.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[pfizer.com][novartis.com][bayer.com]⚠️ Identified Vulnerability:Market Share
Primary Threat Identified:Pfizer
Target Persona:Pharmacy Benefit Managers
🚨 Threat Velocity:7/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)